
Prior Auth Is Costing Billions and Delaying Care. A New Report Says Ban It.
New research from the American Economic Liberties Project (AELP) is making the case for banning the practice of prior authorization as we know it.
Pulling back the curtains on how Big Health is hurting Americans and how we got to this point.
Overdue Last read · last published · next check
Last read 1 day ago, longer than this feed's 12 hours schedule.

New research from the American Economic Liberties Project (AELP) is making the case for banning the practice of prior authorization as we know it.

The FTC’s deal with CVS Caremark requires changes to its drug-pricing practices but comes with no fine, no admission of wrongdoing and no breakup of the health care giant.

Veterans were promised quality options. Optum's clinic closures and provider shortfalls are failing them — and the VA is letting it happen.

After 2026 premium hikes pushed millions out of ACA coverage or into higher-deductible plans, insurers are seeking another round of double-digit increases while spending billions on stock buybacks.

The Health Insurance Influence Tracker (HIIt) shows insurers are on pace to surpass recent campaign spending, with donations targeting leaders and key lawmakers in both parties.

The industry and its biggest players have deeper ties to the Trump Administration than previously reported, even as its executives and customers face billion-dollar fraud charges.

David Cordani transformed Cigna into a $275 billion health care giant. His 17-year tenure mirrored the rise of PBMs, corporate consolidation and mounting legal scrutiny.

Judge dismisses Elevance affiliate's lawsuit with prejudice, finding Congress intended independent dispute resolution—not federal courts—to settle payment disputes.

New analysis shows hospitals are increasingly closing in poorer communities while new facilities are built in wealthier ones, reshaping access to care along economic lines.

The Wall Street Journal's readers deserved the full story about Medicare Advantage.